Startups
Avulux's® patented migraine light sensitivity glasses are clinically proven, they precisely filter light and may, as part of a healthy lifestyle, help people living with migraine.
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 24, 2025 | Avulux Added into the FDA-Funded Consortium for Technology & Innovation in Pediatrics (CTIP) Portfolio | Teenage Avulux wearer excelling at school Avulux today announced that the Consortium for Technology & Innovation in Pediatrics (CTIP) has added Avulux migraine lenses into their product portfolio. At CTIP, we are committed to supporting... |
Reviews 0
FAQ about Avulux
What has the press written about Avulux?
Parsers VC has collected 2 articles mentioning Avulux, among them “Avulux Added into the FDA-Funded Consortium for Technology & Innovation in Pediatrics (CTIP) Portfolio” (Mar 24, 2025).
Is Avulux still active?
Yes, Avulux is active; its latest activity on Parsers VC dates from Aug 25, 2026.